Crisis is cancer care
Medicare only covers 57% of the actual costs of delivering chemotherapy and provided related infusion room services to seniors with cancer: Watch this important video: Cancer Care is in Crisis: Stop The Cancer Care Cuts
Medicare only covers 57% of the actual costs of delivering chemotherapy and provided related infusion room services to seniors with cancer: Watch this important video: Cancer Care is in Crisis: Stop The Cancer Care Cuts
The dreaded sustainable growth rate formula (SGR) that cuts physicians’ Medicare pay takes effect in 61 days (Dec. 1) but already the American Medical Association, 66 specialist practitioner societies and 50 state medical groups, are sounding the alarm. Once again…
According to major cancer organizations such as the Community Oncology Alliance, (COA), if nothing is done, the 23% cut in physician fees Dec. 1, will be followed by another 6.5% cut Jan. 1, reductions that could seriously impair the ability of seniors to access care because many physicians who now accept Medicare beneficiaries will stop doing so.
Watch this video, and pass along to your collegues…
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
